• Corpus ID: 38560618

Commensal Microbiota in Cancer Development and Therapy

  title={Commensal Microbiota in Cancer Development and Therapy},
  author={Mohamed Hassan and Abdelouahid El-Khattouti and Ritesh Tandon and Christian R Gomez},
Cite this article: Hassan M, El-Khattouti A, Tandon R, Gomez CR (2013) Commensal Microbiota in Cancer Development and Therapy. JSM Microbiology 1(1): 1002. Corresponding author Christian R. Gomez, Cancer Institute, Department of Pathology, Department of Radiation Oncology, Department of Microbiology. University of Mississippi Cancer Institute, MS 39216, USA, Tel: 601-815-3060; Fax: 601-815-6806; Email: crgomez@umc.edu 

Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle.

The mechanisms described for pancreatic, lung, colorectal cancer, oral squamous cell carcinoma and hepatocellular carcinoma are analysed and the impact of the current knowledge about the effects of the microbiota on carcinogenesis is analyzed.



Potential role of probiotics on colorectal cancer prevention

Several mechanisms could explain the preventive action of probiotics against colorectal cancer onset: alteration of the intestinal microflora; inactivation of cancerogenic compounds; competition with putrefactive and pathogenic microbiota; improvement of the host’s immune response; and inhibition of tyrosine kinase signaling pathways.

The application of probiotics in cancer

Two types of cancer in which milk fermented by LAB may show a beneficial effect: colon cancer and breast cancer are focused on.

Role of the gut microbiota in immunity and inflammatory disease

Understanding the interaction of the microbiota with pathogens and the host might provide new insights into the pathogenesis of disease, as well as novel avenues for preventing and treating intestinal and systemic disorders.

Oral microbiota and cancer

  • J. Meurman
  • Medicine, Biology
    Journal of oral microbiology
  • 2010
Clinical guidelines and recommendations have been presented to control oral microbiota in patients with malignant disease, but in this area the scientific evidence is weak and more controlled studies are needed for further conclusion.

Normal to cancer microbiome transformation and its implication in cancer diagnosis.

Microbes in gastrointestinal health and disease.

Gaining a fuller understanding of both partners in the normal gut-microbiota interaction may shed light on how the relationship can go awry and contribute to a spectrum of immune, inflammatory, and metabolic disorders and may reveal mechanisms by which this relationship could be manipulated toward therapeutic ends.

Cancer chemopreventive effects of lactic acid bacteria.

This review discusses the recent progresses on the chemopreventive effects of LAB on specific cancer types and the underlying molecular mechanisms.

Epithelial barriers, microbiota, and colorectal cancer.

A recent study suggests that intestinal microbiota may have a mediatory role between the initial steps of tumorigenesis and the initiation of an immune response that influences clinical outcome.